Dudediligence.

aTyr Pharma, Inc

ATYRNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Reported ·

$6,293

3 sales · 3 buys · $962,720 bought

Oct 2025 to Sep 2026

None of the 3 reported sales carry the 10b5-1 box. Together they are under 0.01% of the shares on issue.

REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2025-10-08: SCHIMMEL PAUL, bought2026-02-04: DENYES NANCY, sold2026-02-04: Broadfoot Jill Marie, sold2026-02-04: Shukla Sanjay, sold2026-05-27: SCHIMMEL PAUL, bought
under a no plan named▼ sale▲ buysize is dollars

Form 4 filings, newest first

2026-05-27SCHIMMEL PAUL$50,000
▲ bought100,000 shno plan namedForm 4 ↗
2026-02-04DENYES NANCY$1,096
▼ sold1,118 shno plan namedForm 4 ↗
2026-02-04Broadfoot Jill Marie$1,527
▼ sold1,558 shno plan namedForm 4 ↗
2026-02-04Shukla Sanjay$3,670
▼ sold3,745 shno plan namedForm 4 ↗
2025-10-08SCHIMMEL PAUL$912,720
▲ bought1,000,000 shno plan namedForm 4 ↗